Category ""
ADVERTISING
MGI PHARMA, INC., a biopharmaceutical company, engages in the acquisition, research, development, and commercialization of pharmaceutical products for oncology and acute care applications. The company markets its products through sales organizations in the United States, as well as alliances with other pharmaceutical or biotechnology companies
Tokyo, Japan, January 28, 2008 (U.S. Time) - Eisai Co., Ltd. (Tokyo, TSE 4523) (“Eisai”), a research-based human health care (hhc) company, today announced the successful completion of its acquisition of MGI PHARMA, INC.
MGI Pharma, Inc. is an oncology-focused biopharmaceutical company that acquires, develops, and markets specialty pharmaceutical and medical products for therapeutic markets of unmet needs. The...
MGI Pharma is an oncology-focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. Use the CB Insights Platform to explore MGI Pharma's full profile.
Find company research, competitor information, contact details & financial data for MGI PHARMA of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.
Information on acquisition, funding, investors, and executives for MGI Pharma. Use the PitchBook Platform to explore the full profile.
Explore MGI PHARMA, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 24 news, and 195 literature, Disease Domain:Neoplasms, Immune System Diseases, Hemic and Lymphatic Diseases, Technology Platform:Small molecule drug, Drug:Decitabine, MG-98, MGI-4184, GPI-1216, ZYC-200.
TOKYO--(BUSINESS WIRE)--Eisai Co., Ltd. (Tokyo, TSE 4523) (“Eisai”), a research-based human health care (hhc) company, today announced the successful completion of its acquisition of MGI PHARMA, INC.
MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops, and commercializes proprietary products that address the unmet needs of patients.
MGI Pharma, Inc. 5775 West Old Shakopee Rd. Suite 100 Bloomington, MN 55437-3174 Phone: (952) 346-4700 Toll Free: (800) MGI-4811 FAX: (952) 346-4800 E-mail: ir@mgipharma.com MGI Pharma Homepage. Biomedical Field Pharmaceuticals Business Manufacturing Products Salagen® tablets for treating the symptoms of dry mouth caused by Sjogren's syndrome Hexalen® for recurrent ovarian cancer